ISRCTN15559229已完成Unknown
A study to evaluate efficacy and tolerability of partial enteral nutrition with exclusion diet and its effect on microbiome change in patients with mild to moderate ulcerative colitis: a quasi- experimental study
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients who are confirmed cases of mild to moderate ulcerative colitis
- •2. Age: 18 – 70 years of either gender
- •3. Patients on stable dose of mesalamine for past 4 weeks
- •4. Patients on stable dose of azathioprine/6-mercaptopurine for past 6 months
- •5. Patients on stable doses of topical therapy for past 2 weeks
- •6. Patients who are willing to participate
排除标准
- •1. Received oral steroids in the past 4 weeks
- •2. Received oral antibiotics within past 2 weeks
- •3. Patients with severe disease activity
- •4. Patients with fulminant colitis requiring hospitalization
- •5. Patients who have had surgery
- •6. Patients with concomitant GI infection
- •7. Patients with significant hepatic, renal, endocrine, respiratory, neurologic, or cardiovascular diseases will also be excluded
- •8. Pregnant, lactating females
研究者
相似试验
招募中
4 期
The study to evaluate the efficacy and safety of Polynucleotide on Acne ScarsPolynucleotide, Acne scarAcne scarTCTR20230213003SW HEALTHCARE CO.,LTD27
招募中
4 期
The study to evaluate the efficacy and safety of Polynucleotide for Facial Rejuvenation in ThailandHealthyPolynucleotide, Facial RejuvenationTCTR20230213002SW HEALTHCARE CO.,LTD25
招募中
4 期
The study to evaluate the efficacy and safety of Polynucleotide for Periorbital Rejuvenation in ThailandHealthyPolynucleotide, Periorbital RejuvenationTCTR20230214003SW HEALTHCARE CO.,LTD25
已完成
3 期
Study to evaluate the efficacy and tolerability of Pegfilgrastim in chemotherapy induced neutropeniaCTRI/2009/091/000579GENNOVA BIOPHARMACEUTICALS LTD
已完成
3 期
Study to evaluate the efficacy and tolerability of Filgrastim in chemotherapy induced neutropeniaCTRI/2009/091/000574GENNOVA BIOPHARMACEUTICALS LTD